Are mood disorders and obesity related? A review for the mental health professional

Journal of Clinical Psychiatry

Volumn 65, Issue 5, 2004, Pages 634-651

  McElroy, Susan L ^a   Kotwal, Renu ^a   Malhotra, Shishuka ^b   Nelson, Erik B ^a   Keck Jr , Paul E ^a   Nemeroff, Charles B ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b United Health Network   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT;

ADOLESCENT; AGE; BIOLOGICAL MODEL; CHILD; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MOOD DISORDER; OBESITY; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; MOOD DISORDERS; OBESITY; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 2942718825     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0507     Document Type: Review

References (237)

1. Richardson HB. Obesity as a manifestation of neurosis. Med Clin North Am 1946;30:1187-1202
2. Wadden TA, Stunkard AJ. Psychopathology and obesity. Ann N Y Acad Sci 1987;499:55-65 (Pubitemid 18115889)
3. Friedman MA, Brownell KD. Psychological correlates of obesity: moving to the next research generation. Psychol Bull 1995;117:3-20
4. Pine DS, Cohen P, Brook J, et al. Psychiatric symptoms in adolescence as predictors of obesity in early adulthood: a longitudinal study. Am J Public Health 1997;97:1303-1310 (Pubitemid 27358024)
5. Han TS, Tijhuis MAR, Lean MEJ, et al. Quality of life in relation to overweight and body fat distribution. Am J Public Health 1998;88:1814-1820 (Pubitemid 29017997)
6. Rosmond R, Bjorntorp P. Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes Res 1998;6:338-345 (Pubitemid 128679681)
7. Mann JN, Thakore JH. Melancholic depression and abdominal fat distribution: a mini-review. Stress 1999;3:1-15 (Pubitemid 29462670)
8. Carpenter KM, Hasin DS, Allison DB, et al. Relationships between obesity and DSM-IV major depressive disorders, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health 2000;90:251-257 (Pubitemid 30062678)
9. Roberts RE, Kaplan GA, Shema SJ, et al. Are the obese at greater risk for depression? Am J Epidemiol 2000;152:163-170
10. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002;109:497-504 (Pubitemid 34976676)
11. Roberts RE, Strawbridge WJ, Deleger S, et al. Are the fat more jolly? Ann Behav Med 2002;24:169-180
12. Roberts RE, Deleger S, Strawbridge WJ, et al. Prospective association between obesity and depression: evidence from the Alameda County Study. Int J Obes Relat Metab Disord 2003;27:514-521 (Pubitemid 36520852)
13. Dixon JB, Dixon ME, O'Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 2003;163:2058-2065 (Pubitemid 37151248)
14. Devlin MJ, Yanovski SZ, Wilson GT. Obesity: what mental health professionals need to know. Am J Psychiatry 2000;157:854-866 (Pubitemid 30412334)
15. Faith MS, Matz PE, Jorge MA. Obesity-depression associations in the population. J Psychosom Res 2002;53:935-942
16. Stunkard AJ, Fernstrom MH, Price A, et al. Direction of weight change in recurrent depression: consistency across episodes. Arch Gen Psychiatry 1990;47:857-860 (Pubitemid 20302701)
17. Michelson D, Amsterdam JD, Quitkin FM, et al. Changes in weight during a 1-year trial of fluoxetine. Am J Psychiatry 1999;156:1170-1176 (Pubitemid 29374875)
18. Elmslie JL, Silverstone JT, Mann JI, et al. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000;61:179-184 (Pubitemid 30214513)
19. McElroy SL, Frye MA, Suppes T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-213 (Pubitemid 34407079)
20. Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003;60:112-117 (Pubitemid 36042434)
21. Keck PE Jr, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 2003;64:1426-1435 (Pubitemid 41270100)
22. Black DW, Goldstein RB, Mason EE. Prevalence of mental disorders in 88 morbidly obese bariatric clinic patients. Am J Psychiatry 1992;149:227-234
23. Sullivan M, Karlsson J, Sjörstöm L, et al. Swedish obese subjects (SOS): an intervention study of obesity: baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Int J Obes Relat Metab Disord 1993;17:503-512 (Pubitemid 23269128)
24. Cugini P, Cilli M, Salandri A, et al. Anxiety, depression, hunger and body composition, 3: their relationships in obese patients. Eat Weight Disord 1999;4:115-120
25. Britz B, Siegfried W, Ziegler A, et al. Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study. Int J Obes 2000;24:1707-1714
26. Csabi G, Tenyi T, Molnar D. Depressive symptoms among obese children. Eat Weight Disord 2000;5:43-45
27. Eaton WW, Armenian H, Gallo J, et al. Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care 1996;19:1097-1102 (Pubitemid 26334257)
28. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000;23:1556-1562
29. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-592 (Pubitemid 28340345)
30. Glassman A, Shapiro PA, Ford DE, et al. Cardiovascular health and depression. J Psychiatr Practice 2003;9:409-421 (Pubitemid 37494252)
31. Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604-609 (Pubitemid 37013300)
32. Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 2000;62:463-471 (Pubitemid 30604788)
33. Jones DJ, Bromberger JT, Sutton-Tyrrell K, et al. Lifetime history of depression and carotid atherosclerosis in middle-aged women. Arch Gen Psychiatry 2003;60:153-160 (Pubitemid 36173121)
34. Ackerman S, Nolan LJ. Bodyweight gain induced by psychotropic drugs: incidence, mechanisms and management. CNS Drugs 1998;9:135-151 (Pubitemid 28101535)
35. Zimmermann V, Kraus T, Himmerich H, et al. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 2003;37:193-220 (Pubitemid 36321747)
36. Brown TM, Stoudemire A. Psychiatric Side Effects of Prescription and Over-the-Counter Medications: Recognition and Management. Washington, DC: American Psychiatric Press; 1998
37. Gershon ES, Hamovit JH, Guroff JJ, et al. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch Gen Psychiatry 1987;44:314-319 (Pubitemid 17051318)
38. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
39. Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: The Free Press; 1991
40. Murray CJL, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994;72:495-509
41. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105 (Pubitemid 37432885)
42. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727
43. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-1200 (Pubitemid 33015548)
44. Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-1732
45. Kendler KS, Eaves LJ, Walters EE, et al. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996;53:391-399 (Pubitemid 26149227)
46. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000;157:1552-1562 (Pubitemid 30761024)
47. Kelsoe JR. Arguments for the genetic basis of the bipolar spectrum. J Affect Disord 2003;73:183-197 (Pubitemid 36044646)
48. Faith MS, Johnson SL, Allison DB. Putting the behavior into the behavior genetics of obesity. Behav Genet 1997;27:423-439
49. Bouchard C, Perusse L, Rice T, et al. The genetics of human obesity. In: Bray G, Bouchard C, James WPT, eds. Handbook of Obesity. New York, NY: Marcel Dekker, Inc; 1998:157-190
50. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997;27:325-351 (Pubitemid 27415169)
51. Barsh GS, Farooqui S, O'Rahilly S. Genetics of body-weight regulation. Nature 2000;404:644-651 (Pubitemid 30205069)
52. Branson R, Potoczna N, Kral J, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;348:1096-1103 (Pubitemid 36337320)
53. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, Md: National Institutes of Health; 1998. NIH publication 98-4083
54. National Cholesterol Education Program (NCEP) Expert Panel. Executive summary of the third report of the NCEP Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel). JAMA 2001;285:2486-2497
55. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-581 (Pubitemid 36929310)
56. Keck PE Jr, Buse JB, Dagogo-Jack S, et al. Managing metabolic concerns in patients with severe mental illness. Minneapolis, Minn: Postgraduate Medicine, McGraw-Hill; 2003
57. Pine DS, Goldstein RB, Wolk S, et al. The association between childhood depression and adulthood body mass index. Pediatrics 2001;107:1049-1056 (Pubitemid 32440610)
58. Wyatt RJ, Henter ID, Mojtabai R, et al. Height, weight, and body mass index (BMI) in psychiatrically ill US Armed Forces personnel. Psychol Med 2003;33:363-368 (Pubitemid 36221469)
59. Hasler G, Merikangas K, Eich D, et al. Psychopathology as a risk factor for being overweight. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif. NR106:39-40
60. Muller-Oerlinghausen B, Passoth P-M, Poser W, et al. Impaired glucose tolerance in long-term lithium-treated patients. Int Pharmacopsychiatry 1979;14:350-362 (Pubitemid 10102294)
61. Berken GH, Weinstein DO, Stern WC. Weight gain: a side effect of tricyclic antidepressants. J Affect Disord 1984;7:133-135 (Pubitemid 14028739)
62. Shiori T, Kato T, Murashita J, et al. Changes in the frequency distribution pattern of body weight in patients with major depression. Acta Psychiatr Scand 1993;88:356-360 (Pubitemid 23337561)
63. Elmslie JL, Mann JI, Silverstone JT, et al. Determinants of overweight and obesity in patients with bipolar disorder [CME]. J Clin Psychiatry 2001;62:486-491 (Pubitemid 32717891)
64. Fagiolini A, Frank E, Houck PR, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002;63:528-533 (Pubitemid 34680363)
65. Thakore JH, Richards PJ, Reznek RH, et al. Increased abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997;41:1140-1142 (Pubitemid 27240009)
66. Weber-Hamann B, Hentschel F, Kniest A, et al. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 2002;64:274-277 (Pubitemid 34260465)
67. Fink G, Gottesfeld H, Glickman L. The "superobese" patient. J Hillside Hosp 1962;11:97-119
68. Crumpton E, Wine DB, Groot H. MMPI profiles of obese men and six other diagnostic categories. Psychol Rep 1966;19:1110
69. Atkinson RM, Ringuette EL. A survey of biographical and psychological features in extraordinary fatness. Psychosom Med 1967;29:121-133
70. Leckie EV, Withers RFJ. Obesity and depression. J Psychosom Res 1967;11:107-115
71. Johnson SF, Swenson WM, Gastineau CF. Personality characteristics in obesity: relation to MMPI profile and age of onset of obesity to success in weight reduction. Am J Clin Nutr 1976;29:626-632
72. Lauer JB, Wampler RS, Lantz JB, et al. Psychosocial aspects of extremely obese women joining a diet group. Int J Obes 1979;3:153-161 (Pubitemid 9212376)
73. Leon GR, Kolotkin R, Korgeski G. MacAndrew Addiction scale and other MMPI characteristics associated with obesity, anorexia and smoking behavior. Addict Behav 1979;4:401-407 (Pubitemid 10160568)
74. Wise TN, Fernandez F. Psychological profiles of candidates seeking surgical correction for obesity. Obesity/Bariatric Med 1979;8:83-86
75. Halmi KA, Long M, Stunkard AJ, et al. Psychiatric diagnosis of morbidly obese gastric bypass patients. Am J Psychiatry 1980;137:1470-1472 (Pubitemid 10072255)
76. Hutzler JC, Keen J, Molinari V, et al. Super-obesity: a psychiatric profile of patients electing gastric stapling for the treatment of morbid obesity. J Clin Psychiatry 1981;42:458-462 (Pubitemid 12195275)
77. Hopkinson LC, Bland RC. Depressive syndromes in grossly obese women. Can J Psychiatry 1982;27:213-215 (Pubitemid 12161801)
78. Gentry K, Halverson JD, Heisler S. Psychological assessment of morbidly obese patients undergoing gastric bypass: a comparison of preoperative and postoperative adjustment. Surgery 1984;95:215-220 (Pubitemid 14184232)
79. Gertler R, Ramsey-Stewart G. Pre-operative psychiatric assessment of patients presenting for gastric bariatric surgery (surgical control of morbid obesity). Aust N Z J Surg 1986;56:157-161 (Pubitemid 16129629)
80. Hudson JI, Pope HG Jr, Wurtman JJ, et al. Bulimia in obese individuals: relationship to normal weight bulimia. J Nerv Ment Dis 1988;152:144-152 (Pubitemid 18085139)
81. Prather R, Williamson DA. Psychopathology associated with bulimia, binge eating, and obesity. Int J Eat Disord 1988;7:177-184 (Pubitemid 18070473)
82. Marcus MD, Wing RR, Ewing L, et al. Psychiatric disorders among obese binge eaters. Int J Eat Disord 1990;9:69-77 (Pubitemid 20053070)
83. Goldsmith SJ, Anger-Friedfeld K, Beren S, et al. Psychiatric illness in patients presenting for obesity treatment. Int J Eat Disord 1992;12:63-71
84. Felitti VJ. Childhood sexual abuse, depression, and family dysfunction in adult obese patients: a case control study. South Med J 1993;86:732-736 (Pubitemid 23216338)
85. Wallace WJ, Sheslow D, Hassink S. Obesity in children: a risk for depression. Ann N Y Acad Sci 1993;699:301-303 (Pubitemid 23360002)
86. Specker S, deZwaan M, Raymond N, et al. Psychopathology in subgroups of obese women with and without binge eating disorder. Compr Psychiatry 1994;35:185-190
87. Goldstein LT, Goldsmith SJ, Anger K, et al. Psychiatric symptoms in clients presenting for commercial weight reduction treatment. Int J Eat Disord 1996;20:191-197 (Pubitemid 26274621)
88. Powers PS, Rosemurgy A, Boyd F, et al. Outcome of gastric restriction procedures: weight, psychiatric diagnoses, and satisfaction. Obes Surg 1997;7:471-477 (Pubitemid 28039436)
89. Kalarchian MA, Wilson GT, Brolin RE, et al. Binge eating in bariatric surgery patients. Int J Eat Disord 1998;23:89-92 (Pubitemid 128682864)
90. Musante GJ, Costanto PR, Friedman KE. The comorbidity of depression and eating dysregulation in a diet-seeking obese population: a matter of gender specificity. Int J Eat Disord 1998;23:65-75 (Pubitemid 128682861)
91. Saunders R. Binge eating in gastric bypass patients before surgery. Obes Surg 1999;9:72-76 (Pubitemid 29137655)
92. Katz JR, Taylor NF, Goodrick S, et al. Central obesity, depression, and the hypothalamo-pituitary-adrenal axis in men and postmenopausal women. Int J Obes 2000;24:246-251 (Pubitemid 30107576)
93. Wadden TA, Sarwer DB, Womble LG, et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001;81:1001-1024 (Pubitemid 32895997)
94. Hsu LKG, Mulliken B, McDonagh B, et al. Binge eating disorder in extreme obesity. Int J Obes 2002;26:1398-1403 (Pubitemid 35221890)
95. Moore ME, Stunkard A, Srole L. Obesity, social class, and mental illness. JAMA 1962;181:962-966
96. Silverstone JT. Obesity. Proc R Soc Med 1968;61:371-375
97. Holland J, Masling J, Copely D. Mental illness in lower class normal, obese and hyperobese women. Psychosom Med 1970;32:351-357
98. Sallade J. A comparison of the psychological adjustment of obese vs non-obese children. J Psychosom Res 1973;17:89-96
99. Crisp AH, McGuiness B. Jolly fat: relation between obesity and psychoneurosis in a general population. Br Med J 1979;1:7-9
100. Crisp AH, Queenan M, Sittampaln Y, et al. "Jolly fat" revisited. J Psychosom Res 1980;24:233-241 (Pubitemid 11166000)
101. Hällström T, Noppa H. Obesity in women in relation to mental illness, social factors and personality traits. J Psychosom Res 1981;25:75-82 (Pubitemid 11118025)
102. Stewart AL, Brook RH. Effects of being overweight. Am J Public Health 1983;73:171-178 (Pubitemid 14191008)
103. Rothschild M, Peterson HR, Pfeifer MA. Depression in obese men. Int J Obes 1989;13:479-485
104. Wadden TA, Foster GD, Stunkard AJ, et al. Dissatisfaction with weight and figure in obese girls: discontent but not depression. Int J Obes 1989;13:89-97 (Pubitemid 19060107)
105. Lapidus L, Bengtsson C, Hällström T, et al. Obesity, adipose tissue distribution and health in women: results from a population study in Gothenberg, Sweden. Appetite 1989;12:25-35
106. Wing RR, Matthews KA, Kuller LH, et al. Waist to hip ratio in middle-aged women: associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler Thromb 1991;11:1250-1257
107. Istvan J, Zavela K, Weidner O. Body weight and psychological distress in the NHANES I. Int J Obes 1992;16:999-1003 (Pubitemid 23010024)
108. Georges E, Mueller WH, Wear ML. Body fat distribution in men and women of the Hispanic health and nutrition examination survey of the United States: associations with behavioral variables. Ann Hum Biol 1993;20:275-291
109. Gortmaker SL, Must A, Perrin JM, et al. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993;329:1008-1012 (Pubitemid 23307910)
110. Ross C. Overweight and depression. J Health Soc Behav 1994;35:63-79
111. Foreyt JP, Brunner RL, Goodrick GK, et al. Psychological correlates of reported physical activity in normal-weight and obese adults: the Reno diet-heart study. Int J Obes 1995;19(suppl 4):S69-S72
112. Palinkas LA, Wingard DL, Barret-Connort E. Depressive symptoms in overweight and obese older adults: a test of the "jolly fat" hypothesis. J Psychosom Res 1996;40:59-66
113. Rosmond R, Lapidus L, Marin P, et al. Mental distress, obesity, and body fat distribution in middle-aged men. Obes Res 1996;4:245-252 (Pubitemid 126690227)
114. Räikkönen K, Keltikangas-Järvinen L, Adlercreutz H, et al. Psychosocial stress and the insulin resistance syndrome. Metabolism 1996;45:1533-1538 (Pubitemid 26424583)
115. Rosmond R, Bjorntorp P. Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity. Metabolism 1998;47:1187-1193 (Pubitemid 28469242)
116. Haukkala A, Uutela A. Cynical hostility, depression, and obesity: the moderating role of education and gender. Int J Eat Disord 2000;27:106-109 (Pubitemid 30013242)
117. Erickson SJ, Robinson TN, Haydel KF, et al. Are overweight children unhappy? body mass index, depressive symptoms, and overweight concerns in elementary school children. Arch Pediatr Adolesc Med 2000;154:931-935 (Pubitemid 30692278)
118. Pesa JA, Syre TR, Jones E. Psychological differences associated with body weight among female adolescents: the importance of body image. J Adolesc Health 2000;26:330-337 (Pubitemid 30207010)
119. Siegel JM, Yancery AK, McCarthy WJ. Overweight and depressive symptoms among African-American women. Prev Med 2000;31:232-240 (Pubitemid 30679846)
120. Ahlberg AC, Ljung T, Rosmond R, et al. Depression and anxiety symptoms in relation to anthropometry and metabolism in men. Psychiatry Res 2002;112:101-110 (Pubitemid 35341464)
121. Bulik CM, Sullivan PF, Kendler KS. Medical and psychiatric morbidity in obese women with and without binge eating. Int J Eat Disord 2002;32:72-78 (Pubitemid 34569151)
122. Marniemi J, Kronhalm E, Aunola S, et al. Visceral fat and psychosocial stress in identical twins discordant for obesity. J Int Med 2002;251:35-43 (Pubitemid 34209072)
123. Onyike CV, Crum RM, Lee HB, et al. Is obesity associated with major depression? results from the Third National Health and Nutrition Examination Survey. Am J Epidemiology 2003;158:1139-1147 (Pubitemid 37548783)
124. Jacobs SB, Wagner MK. Obese and nonobese individuals: behavioral and personality characteristics. Addict Behav 1984;9:223-226 (Pubitemid 14115013)
125. Fitzgibbon ML, Stolley MR, Kirschenbaum DS. Obese people who seek treatment have different characteristics than those who do not seek treatment. Health Psychol 1993;12:346-353
126. Lichtman SW, Pisarka K, Berman ER, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992;327:1893-1898 (Pubitemid 23006963)
127. Wolff EA III, Putnam FW, Post RM. Motor activity and affective illness: the relationship of amplitude and temporal distribution to changes in affective state. Arch Gen Psychiatry 1985;42:288-294 (Pubitemid 15016118)
128. Posternak MA, Zimmerman M. Partial validation of the atypical features subtype of major depressive disorders. Arch Gen Psychiatry 2002;59:70-76 (Pubitemid 34044409)
129. Levitan RD, LeSage A, Parikh SV, et al. Reversed neurovegetative symptoms of depression: a community study of Ontario. Am J Psychiatry 1997;154:934-940 (Pubitemid 27274535)
130. Angst J, Gamma A, Sellaro R, et al. Toward validation of atypical depression in the community: results of the Zurich Cohort Study. J Affect Disord 2002:72;125-138 (Pubitemid 35007357)
131. Sullivan PF, Prescott CA, Kendler KS. The subtypes of major depression in a twin registry. J Affect Disord 2002;68:273-284 (Pubitemid 34632666)
132. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002;7:254-275 (Pubitemid 34280634)
133. Silverstein B. Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am J Psychiatry 1999;156:480-482 (Pubitemid 29124176)
134. O'Rourke D, Wurtman JJ, Wurtman RJ, et al. Treatment of seasonal depression with d-fenfluramine. J Clin Psychiatry 1989;50:343-347
135. Brzezinski AA, Wurtman JJ, Wurtman RJ, et al. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obst Gynecol 1990;76:296-301 (Pubitemid 20227476)
136. Noppa H, Hällström T. Weight gain in adulthood in relation to socioeconomic factors, mental illness and personality traits: a prospective study of middle-aged women. J Psychosom Res 1981;25:83-89 (Pubitemid 11118026)
137. DiPietro L, Anda RF, Williamson DF, et al. Depressive symptoms and weight change in a national cohort of adults. Int J Obes 1992;16:745-753
138. Barefoot JC, Heitmann BL, Helms MJ, et al. Symptoms of depression and changes in body weight from adolescence to mid-life. Int J Obes 1998;22:688-694 (Pubitemid 28312782)
139. Spitzer RL, Devlin M, Walsh BT, et al. Binge eating disorder: a multi-site field trial of the diagnostic criteria. Int J Eat Disord 1992;11:191-203
140. Yanovski SZ, Nelson JE, Dubbert BK, et al. Association of binge eating disorders and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993;150:1472-1479 (Pubitemid 23289302)
141. Fairburn CG, Welch SL, Doll HA, et al. Risk factors for bulimia nervosa: a community based case-control study. Arch Gen Psychiatry 1997;54:509-517 (Pubitemid 27258548)
142. Robertson DN, Palmer RL. The prevalence and correlates of binge eating in a British community sample of women with a history of obesity. Int J Eat Disord 1997;22:323-327 (Pubitemid 27371990)
143. Fairburn CG, Doll HA, Welch SL, et al. Risk factors for binge eating disorder: a community-based, case-control study. Arch Gen Psychiatry 1998;55:425-432 (Pubitemid 28237276)
144. Smith DE, Marcus MD, Lewis CE, et al. Prevalence of binge eating disorder, obesity, and depression in a biracial cohort of young adults. Ann Behav Med 1998;20:227-232 (Pubitemid 29072339)
145. French SA, Jeffery RW, Sherwood NE, et al. Prevalence and correlates of binge eating in a nonclinical sample of women enrolled in a weight gain prevention program. Int J Obes 1999;23:576-585 (Pubitemid 29276806)
146. Bulik CM, Sullivan PF, Kendler KS. An empirical study of the classification of eating disorders. Am J Psychiatry 2000;157:886-895 (Pubitemid 30412338)
147. Fairburn CG, Cooper Z, Doll HA, et al. The natural course of bulimia nervosa and binge eating disorders in young women. Arch Gen Psychiatry 2000;57:659-665 (Pubitemid 30445857)
148. Ackard DM, Neumark-Sztainer D, Story M, et al. Overeating among adolescents: prevalence and associations with weight-related characteristics and psychological health. Pediatrics 2003;111:67-74 (Pubitemid 36071033)
149. Kendler KS, MacLean C, Neale M, et al. The genetic epidemiology of bulimia nervosa. Am J Psychiatry 1991;148:1627-1637
150. Vollrath M, Koch R, Angst J. Binge eating and weight concerns among young adults: results from The Zurich Cohort Study. Br J Psychiatry 1992;160:498-503
151. Garfinkel PE, Lin E, Goering P, et al. Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups. Am J Psychiatry 1995;152:1052-1058
152. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998;50:143-151 (Pubitemid 28551784)
153. Wittchen HU, Mhlig S, Pezawas L. Natural course and burden of bipolar disorders. Int J Neuropsychopharmacol 2003;6:145-154 (Pubitemid 36850967)
154. Saltzman E, Benotti PN. The effects of obesity on the cardiovascular system. In: Bray GA, Bouchard C, James WPT, eds. Handbook of Obesity. New York, NY: Marcel Dekker; 1998:637-649
155. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529 (Pubitemid 29504045)
156. Folsom AR, Kushi LH, Anderson KS, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med 2000;160:2117-2128 (Pubitemid 30482717)
157. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-1848 (Pubitemid 28544425)
158. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-2217 (Pubitemid 29196806)
159. Ferketich AK, Schwartzbaum JA, Frid DJ, et al. Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch Intern Med 2000;160:1261-1268 (Pubitemid 30252771)
160. Ohira T, Hiroyasu I, Satoh S, et al. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 2001;32:903-908 (Pubitemid 32285158)
161. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study. Arch Fam Med 1997;6:43-49
162. Lilliker SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry 1980;21:270-275 (Pubitemid 10027833)
163. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417-1420 (Pubitemid 29416540)
164. Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002;70:19-26 (Pubitemid 34756609)
165. Calle EE, Thun MJ, Petrelli J, et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341:1097-1105 (Pubitemid 29466221)
166. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life table analysis. Ann Intern Med 2003;138:24-32 (Pubitemid 36232091)
167. Lakka H-M, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular mortality in middle-aged men. JAMA 2002;288:2709-2716 (Pubitemid 35403784)
168. Hoyer EH, Mortensen PB, Olesen AV. Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. Br J Psychiatry 2000;176:76-82
169. Ösby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorders in Sweden. Arch Gen Psychiatry 2001;58:844-850 (Pubitemid 32979302)
170. Pennix BWJH, Beekman ATF, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-227 (Pubitemid 32209674)
171. Black DW, Goldstein RB, Mason EE, et al. Depression and other mental disorders in the relatives of morbidly obese patients. J Affect Disord 1992;25:91-96
172. Björntorp P, Rosmond R. Hypothalamic origin of the metabolic syndrome X. Ann N Y Acad Sci 1999;892:297-307
173. Björntorp P, Rosmond R. Obesity and cortisol. Nutrition 2000;16:924-936 (Pubitemid 30777346)
174. Vincennati V, Pasquali R. Abnormalities of the hypothalamic-pituitary- adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J Clin Endocrinol Metabol 2000;85:4093-4098 (Pubitemid 32055358)
175. Duclos M, Gatta B, Corcuff J-B, et al. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary- adrenal axis activity and sensitivity to glucocorticoids. Clin Endocrinol 2002;55:447-454 (Pubitemid 32955481)
176. Schatzberg AF, Garlow SJ, Nemeroff CB. Molecular and cellular mechanisms in depression. In: Davis KL, Charney D, Coyle JT, et al, eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, Pa: Lippincott Williams & Willkins; 2002:1011-1015
177. Strombom U, Krotkiewski M, Blennow K, et al. The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution. Int J Obes 1996;20:361-368 (Pubitemid 26110412)
178. Lambert GW, Vaz M, Cox HS, et al. Human obesity is associated with chronic elevation in brain 5-hydroxytryptamine turnover. Clin Sci 1999;96:191-197 (Pubitemid 29094939)
179. Wang G-J, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001;357:354-357 (Pubitemid 32128542)
180. Mercer JG, Haggard N, Morgan PJ. Leptin and obesity: the story so far and its therapeutic implications. CNS Drugs 2000;14:413-424 (Pubitemid 32042673)
181. Antonijevic IA, Murck H, Frieboes RM, et al. Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res 1998;32:403-410 (Pubitemid 28491246)
182. Rubin RT, Rhodes ME, Czambel RK. Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls. Psychiatry Res 2002;113:255-268 (Pubitemid 36136048)
183. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17:953-966
184. Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002;89:419-424 (Pubitemid 34142517)
185. Wright JH, Jacism JJ, Radin NS, et al. Glucose metabolism in unipolar depression. Br J Psychiatry 1978;132:386-393 (Pubitemid 8312597)
186. Menna-Perper M, Rochford J, Meuller PS, et al. Differential response of plasma glucose, amino acids and non-esterified fatty acids to insulin in depressed patients. Psychoneuroendocrinology 1984;9:161-171 (Pubitemid 14089186)
187. Winokur A, Maislin G, Phillips JL, et al. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry 1988;145:325-330 (Pubitemid 18078312)
188. Okamura F, Tashiro A, Utsumi A, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000;49:1255-1260 (Pubitemid 30787013)
189. Rasgon NL, Altshuler LL, Elman MA, et al. Increased insulin resistance in women with bipolar disorder. Presented at the 155th annual meeting American Psychiatric Association; May 18-23, 2002; Philadelphia, Pa
190. Horsten M, Wamala SP, Vingerhoets A, et al. Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosom Med 1997;59:521-528 (Pubitemid 27422250)
191. Bjorntorp P. Etiology of the metabolic syndrome. In: Bray GA, Bonchard C, James WPT, eds. Handbook of Obesity. New York, NY: Marcel Dekker; 1998:573-600
192. Rasgon NL, Rao RC, Hwang S, et al. Depression in women in polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003;74:299-304 (Pubitemid 36555931)
193. Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev 1999;20:805-875 (Pubitemid 30647075)
194. Chiarello RJ, Cole JO. The use of psychostimulants in general psychiatry: a reconsideration. Arch Gen Psychiatry 1987;44:286-295 (Pubitemid 17023144)
195. Satel SL, Nelson JC. Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 1989;50:241-249 (Pubitemid 19193447)
196. Fawcett J, Busch KA. Stimulants in psychiatry. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. 2nd ed. Washington, DC: American Psychiatric Press; 1998:503-522
197. Rickels K, Hesbacher P, Fisher E, et al. Emotional symptomatology in obese patients treated with fenfluramine and dextroamphetamine. Psychol Med 1976;6:623-630
198. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995;152:929-931
199. Yanovski SZ, Yanovski JA. Drug therapy: obesity. N Engl J Med 2002;346:591-602
200. Murphy DL, Slater S, de la Vega CE, et al. The serotonergic neurotransmitter system in the affective disorders: a preliminary evaluation of the antidepressant and antimanic effects of fenfluramine. In: Deniker P, Radonco-Thomas C, Villeneuve A, eds. Neuropsychopharmacology. New York, NY: Pergamon Press; 1978:675-682
201. Blouin AG, Blouin JH, Perez EL, et al. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988;8:261-269 (Pubitemid 18218490)
202. Harvey AT, Rudolph RL, Preskom SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 2000;57:503-509 (Pubitemid 30257265)
203. Buckett WR, Thomas PL, Luscombe GP. The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:575-584
204. Appolinario JC, Bacaltchuk J, Sichieri R, et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 2003;60:1109-1116
205. Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(suppl 1):566-571 (Pubitemid 30202345)
206. Leppik IE. Zonisamide, a novel antiepileptic agent. Today's Therapeutic Trends 1999;17:181-195 (Pubitemid 29525777)
207. Gadde KM, Francicy DM, Wagner HR, et al. Zonisamide for weight loss in obese adults: a randomized, controlled trial. JAMA 2003;289:1820-1825 (Pubitemid 37430252)
208. Bray G A, Hollander P, Klein S, et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;11:722-733 (Pubitemid 41151598)
209. McElroy SL, Keck PE Jr. Topiramate. In: Schatzberg AF, Nemeroff CB, eds. American Psychiatric Publishing Textbook of Psychopharmacology. 3rd ed. Arlington, Va: American Psychiatric Publishing; 2004:627-636
210. McIntyre RS, Mancini DA, McCann S, et al. Topiramate vs bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 2002;4:207-213 (Pubitemid 34591247)
211. Kanba S, Yagi G, Kamijima K, et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:707-715 (Pubitemid 24238876)
212. Levine LR, Enas GG, Thompson WL, et al. Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study. Int J Obes 1989;13:635-645
213. Wise SD. Clinical studies with fluoxetine in obesity. Am J Clin Nutr 1992;55(suppl 1):181S-184S
214. Sayler ME, Goldstein DJ, Roback PJ, et al. Evaluating success of weight-loss programs, with an application to fluoxetine weight-reduction clinical trial data. Int J Obes Relat Metab Disord 1994;18: 742-751 (Pubitemid 24334518)
215. Gadde KM, Parker CB, Maner LG, et al. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res 2001;9:544-551 (Pubitemid 33610175)
216. Anderson JW, Greenway FL, Fujioka K, et al. Bupropion SR enhances weight loss: a 48-week double-blind, placebo-controlled trial. Obes Res 2002;10:633-641 (Pubitemid 135688262)
217. Jain AK, Kaplan RA, Gadde KM, et al. Bupropion SR vs placebo for weight loss in obese patients with depressive symptoms. Obes Res 2002;10:1049-1056 (Pubitemid 135688922)
218. Rudolph RL, Fabre LF, Feighner JP, et al. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 1998;59:116-122 (Pubitemid 28150857)
219. Kraus T, Haack M, Schuld A, et al. Body weight, the tumor necrosis factor system and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 2002;35:220-225 (Pubitemid 36061311)
220. Malhotra S, King KH, Welge JA, et al. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. J Clin Psychiatry 2002;63:802-806
221. Thase ME, Entsuah AR, Rudulph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-241 (Pubitemid 32183606)
222. Stahl S, Entsuah R, Rudolph RL. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiatry 2002;52:1166-1174 (Pubitemid 35477672)
223. Learned-Coughlin SM, Bergström M, Savitcheva I, et al. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 2003;54:800-805
224. Dong J, Blier P. Modification of norepinephrine and serotonin, but not dopamine, neuronal firing by bupropion treatment. Psychopharmacology (Berl) 2001;155:52-57 (Pubitemid 32295769)
225. Johnson JG, Cohen P, Kasen S, et al. Childhood adversities associated with risk for eating disorders or weight problems during adolescence or early adulthood. Am J Psychiatry 2002;159:394-400 (Pubitemid 34184733)
226. Johnson JG, Cohen P, Kasen S, et al. Association of maladaptive parental behavior with psychiatric disorder among parents and their offspring. Arch Gen Psychiatry 2001;58:453-460 (Pubitemid 32411325)
227. Phelan S, Wadden TA. Combining behavioral and pharmacological treatments for obesity. Obes Res 2002;10:560-574
228. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997;54:1009-1015 (Pubitemid 27476096)
229. Rasgon NL, Carter MS, Elman S, et al. Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Curr Drug Targets Immune Endocr Metabol Disord 2002;2:97-102
230. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder [Revision]. Am J Psychiatry 2000;157(suppl 4):1-45 (Pubitemid 30193855)
231. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder [Revision]. Am J Psychiatry 2002;159(suppl 4):1-50 (Pubitemid 34274969)
232. Malhotra S, McElroy SL. Medical management of obesity associated with mental disorders. J Clin Psychiatry 2002;63(suppl 4):24-32 (Pubitemid 34242108)
233. Clark MM, Niaura R, King TK, et al. Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav 1996;21:509-513 (Pubitemid 26194610)
234. McElroy SL, Suppes T, Keck PE Jr, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000;47:1025-1033 (Pubitemid 30336210)
235. Yang Y, Nowakoska C, Becker OV, et al. Weight loss during the first two months of open adjunctive zonisamide for obesity in bipolar disorder patients. In: New Research Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif. Abstract NR14:5-6
236. Dursun SM, Devarajan S. Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action? [letter] Can J Psychiatry 2001;46:287-288 (Pubitemid 32423999)
237. Carpenter LL, Leon Z, Yasmin S, et al. Do obese depressed patients respond to topiramate? a retrospective chart review. J Affect Disord 2002;69:251-255 (Pubitemid 34722892)